Posted on: 09 December, 2024
The Kolling Institute’s Professor Sue Kurrle and her team at the Rehabilitation and Aged Care Network at Hornsby Ku-ring-gai Hospital have been running clinical trials for 25 years, looking at dementia, frailty, and falls to name just some areas.
“We do trials as it keeps you cutting edge and they are really important for our patients,” she says.
As a geriatrician on the frontline, Sue is well posi.....
Read more
Category: Neuroscience and Pain Research, New Treatment, Research Excellence
Posted on: 12 November, 2024
Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There's a focus too on the first steps towards gene therapy for Meniere's disease, the latest research into treatments for dementia and.....
Read more
Category: New Treatment, Newsletters, Research Excellence
Posted on: 30 January, 2023
Two of our outstanding Kolling Institute researchers have been recognised in this year’s Australia Day honours roll.
Professor Sue Kurrle has been appointed an Officer of the Order of Australia (AO) for distinguished service to medicine as a geriatrician, and to research into dementia and cognitive decline.
Sue works at Hornsby Ku-ring-gai and Batemans Bay Hospitals, specialising in dementia, frail.....
Read more
Category: Awards, Research Excellence
Posted on: 05 September, 2019
Congratulations to Professor David Hunter who’s received a prestigious University of Sydney Vice Chancellor’s award for outstanding research.
The Kolling researcher and rheumatology clinician is regarded as the world’s leading expert in osteoarthritis.
Professor Hunter’s research has had a significant and lasting impact in the field of osteoarthritis, influencing clinical practice and access to ev.....
Read more
Category: Awards, New Treatment
Posted on: 22 July, 2019
The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase.
Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain.
RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the disease to indivi.....
Read more
Category: New Treatment